##  [LNP023](/node/39076 "LNP023") 

  



Fabhalta®

[Oncology: Hematology](/taxonomy/term/5716)

[Phase 3](/taxonomy/term/2776)

[≥ 2029](/taxonomy/term/11576)

[CFB inhibitor](/taxonomy/term/3071)

 

Atypical Hemolytic Uremic Syndrome (aHUS)

[Supplementary Indication](/taxonomy/term/2791)



- [Print](/node/39076/printable/print)
- [PDF](/node/39076/printable/pdf)